DK1658063T3 - Fordelagtige kombinationer til inhalering af nacystelyn og bronkodilatorer - Google Patents
Fordelagtige kombinationer til inhalering af nacystelyn og bronkodilatorerInfo
- Publication number
- DK1658063T3 DK1658063T3 DK03817895.0T DK03817895T DK1658063T3 DK 1658063 T3 DK1658063 T3 DK 1658063T3 DK 03817895 T DK03817895 T DK 03817895T DK 1658063 T3 DK1658063 T3 DK 1658063T3
- Authority
- DK
- Denmark
- Prior art keywords
- nacystline
- codilators
- inhalation
- source
- beneficial combinations
- Prior art date
Links
- 230000009286 beneficial effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/BE2003/000134 WO2005013963A1 (en) | 2003-08-06 | 2003-08-06 | Advantageous combinations for inhalation of nacystelyn and bronchodilators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1658063T3 true DK1658063T3 (da) | 2014-05-12 |
Family
ID=34120384
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03817895.0T DK1658063T3 (da) | 2003-08-06 | 2003-08-06 | Fordelagtige kombinationer til inhalering af nacystelyn og bronkodilatorer |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20070071689A1 (da) |
| EP (1) | EP1658063B1 (da) |
| AU (1) | AU2003254429A1 (da) |
| CA (1) | CA2534934A1 (da) |
| DK (1) | DK1658063T3 (da) |
| ES (1) | ES2471139T3 (da) |
| WO (1) | WO2005013963A1 (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1944018A1 (en) * | 2007-01-10 | 2008-07-16 | CHIESI FARMACEUTICI S.p.A. | Micronised particles of low-dosage strength active agents for powder formulations for inhalation |
| CN113018444A (zh) * | 2020-01-09 | 2021-06-25 | 海南斯达制药有限公司 | 治疗呼吸系统疾病的药物组合物及其制备方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LU84095A1 (fr) * | 1982-04-19 | 1983-12-16 | Galephar | Sels d'acetylcysteine,leur preparation et leur utilisation |
| JP3042866B2 (ja) | 1989-09-08 | 2000-05-22 | グラクソ・グループ・リミテッド | 呼吸疾患治療薬 |
| IL95590A (en) | 1989-09-08 | 1996-06-18 | Glaxo Group Ltd | Medicinal preparations containing Salmetrol and Pluticasone Propionate |
| ES2172510T3 (es) | 1991-12-18 | 2002-10-01 | Astrazeneca Ab | Nueva combinacion de formoterol y budesonida. |
| ZA94155B (en) * | 1992-11-06 | 1995-07-11 | Adcock Ingram Pharma | Pharmaceutical composition |
| ZA963590B (en) | 1995-05-10 | 1996-11-19 | Adcock Ingram Ltd | Pharmaceutical composition |
| CN1253508A (zh) * | 1997-04-30 | 2000-05-17 | 沃尼尔-朗伯公司 | 局部鼻用抗炎组合物 |
| EP0876814A1 (en) | 1997-05-07 | 1998-11-11 | "PHARLYSE", Société Anonyme | Dry powder inhaler excipient, process for its preparation and pharmaceutical compositions containing it |
| US6153187A (en) | 1997-09-02 | 2000-11-28 | Insight Strategy & Marketing Ltd. | Use of glycosaminoglycans degrading enzymes for management of airway associated diseases |
| US5969421A (en) | 1997-11-18 | 1999-10-19 | Lucent Technologies Inc. | Integrated circuit conductors that avoid current crowding |
| CA2338680C (en) * | 1998-08-04 | 2008-10-14 | Jago Research Ag | Medicinal aerosol formulations |
| GB9818548D0 (en) | 1998-08-25 | 1998-10-21 | Microbiological Res Authority | Treatment of mucas hypersecretion |
| PE20020387A1 (es) * | 2000-08-31 | 2002-06-24 | Glaxo Group Ltd | Uso de una combinacion de salmeterol y fluticasona |
| US7931022B2 (en) * | 2001-10-19 | 2011-04-26 | Respirks, Inc. | Method and apparatus for dispensing inhalator medicament |
| US20060254583A1 (en) * | 2003-03-20 | 2006-11-16 | Arthur Deboeck | Dry powder inhaler system |
-
2003
- 2003-08-06 DK DK03817895.0T patent/DK1658063T3/da active
- 2003-08-06 ES ES03817895.0T patent/ES2471139T3/es not_active Expired - Lifetime
- 2003-08-06 CA CA002534934A patent/CA2534934A1/en not_active Abandoned
- 2003-08-06 AU AU2003254429A patent/AU2003254429A1/en not_active Abandoned
- 2003-08-06 WO PCT/BE2003/000134 patent/WO2005013963A1/en not_active Ceased
- 2003-08-06 US US10/567,408 patent/US20070071689A1/en not_active Abandoned
- 2003-08-06 EP EP03817895.0A patent/EP1658063B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1658063B1 (en) | 2014-03-12 |
| US20070071689A1 (en) | 2007-03-29 |
| WO2005013963A1 (en) | 2005-02-17 |
| AU2003254429A1 (en) | 2005-02-25 |
| ES2471139T3 (es) | 2014-06-25 |
| CA2534934A1 (en) | 2005-02-17 |
| EP1658063A1 (en) | 2006-05-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1824475T3 (da) | Fremgangsmåde til oprensning af trans-(-)-delta9-tetrahydrocannabinol og trans-(+)-delta9-tetrahydrocannabinol | |
| DK1667986T3 (da) | Acetonesolvat af dimethoxydocetaxel og fremgangsmåde til fremstilling heraf | |
| DK1638999T3 (da) | Sammensætninger og fremgangsmåder til øgning af knoglemineralisering | |
| DK1842399T4 (da) | Belysningsapparat og fremgangsmåde | |
| IS7977A (is) | Samsetningar og aðferð til samsettra meðferðar | |
| DK1830838T3 (da) | Sammensætninger og fremgangsmåder til behandling af neoplastiske sygdomme | |
| DK1644021T3 (da) | Fremgangsmåder og sammensætninger til behandlingen af gastrointestinale sygdomme | |
| DK1831154T3 (da) | Fremstilling af pregabalin og relaterede forbindelser | |
| DK1740197T3 (da) | Prolyl-endopeptidease (PEP) og glutamin-endoprotease til behandlingen af cøliaki | |
| DK1805312T3 (da) | Fremgangsmåder og midler til fremstilling af hyaluronan | |
| IS8597A (is) | Samsetningar rísedrónats og aðferðir við notkun þess | |
| IS8305A (is) | Bindandi smíðar og aðferðir við notkun þeirra | |
| NO20055211D0 (no) | Anti-fungale forbindelser og fremgangsmater for anvendelse | |
| DK1944322T3 (da) | Behandling af TNFalfa-relaterede sygdomme | |
| DK2075000T3 (da) | Kombination af azelastin og ciclesonid | |
| DK1934179T3 (da) | Fremgangsmåder og mellemprodukter | |
| DK2508521T4 (da) | Dimaleat af en aminocrotonylforbindelse og fremgangsmåde til fremstilling deraf | |
| DK1812895T3 (da) | Stofkilde | |
| DK3321359T3 (da) | Variante former af uratoxidase og anvendelse deraf | |
| NO20033854L (no) | N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse | |
| DK1478438T3 (da) | Fremgangsmåder og sammensætninger til behandling af astma | |
| DK1601744T3 (da) | Forgasningsapparat og fremgangsmåde | |
| DK2305689T3 (da) | Syntese af naturligt forekommende ecteinascidiner og relateredeforbindelser | |
| DK1599469T3 (da) | Tetrazolderivater og fremgangsmåder til behandling af metabolismerelaterede forstyrrelser dermed | |
| DK1589973T4 (da) | Formulering og fremgangsmåder til behandling af thrombocytæmi |